Forecasting The Future: 7 Analyst Projections For Inari Medical
Portfolio Pulse from Benzinga Insights
Inari Medical (NASDAQ:NARI) has been the subject of varied analyst opinions over the past three months, with 7 analysts offering insights ranging from bullish to bearish. The average 12-month price target for NARI has been adjusted to $65.57, down from $72.00, indicating a 8.93% decrease. Analyst actions include maintaining, raising, and lowering ratings and price targets, reflecting their reaction to Inari Medical's performance and market conditions. Inari Medical, a medical device company, has shown notable revenue growth and strong financial health indicators such as net margin, ROE, and ROA, despite a market capitalization below industry averages.
March 22, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Inari Medical has seen a mix of analyst ratings, with a recent decrease in the average price target to $65.57, reflecting a more cautious outlook. Despite this, the company's strong financial health and revenue growth are positive indicators.
The mixed analyst ratings and the decrease in the average price target suggest a cautious outlook in the short term. However, Inari Medical's strong financial health and revenue growth are significant factors that could support the stock price. The relevance of this news to NARI is direct, and its importance is high given the potential impact on investor perception and stock price. The confidence level reflects the clear data provided on analyst ratings and financial health indicators.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100